There is mounting evidence that prospective memory (PM) is impaired during HIV infection despite treatment. In this prospective study, 66 adults (43 HIV+ and 23 HIV negative) underwent PM assessment and cerebrospinal fluid (CSF) examination. HIV+ participants had significantly lower PM but significantly higher CSF concentrations of CXCL10 and quinolinic acid (QUIN). Higher CSF phosphorylated Tau (pTau) was associated with worse PM. In a secondary analysis excluding outliers, higher QUIN correlated with higher pTau. CSF QUIN is thus elevated during HIV infection despite antiretroviral therapy and could indirectly contribute to impaired PM by influencing the formation of pTau.
Introduction
HIV-associated neurocognitive disorders (HAND) are persistently common in the combination antiretroviral (cART) era. Up to 40% of HIV+ adults with undetectable plasma HIV RNA levels and minimal neuropsychological comorbidities have at least mild neurocognitive impairment (Heaton et al., 2010) . Biological evidence of ongoing neuronal damage during cART comes from magnetic resonance spectroscopy studies as well as studies of neuronal injury biomarkers such as neurofilament-light (Harezlak et al., 2011; Jessen Krut et al., 2014 ). Yet, the underlying pathogenesis of neuronal damage during cART remains poorly understood.
While inflammation persists during treated HIV and may be a cause of neuronal damage (Zayyad and Spudich, 2015) , other processes could also contribute to HAND pathogenesis. Quinolinic acid (QUIN), for example, is a neurotoxin that is a product of the kynurenine pathway for tryptophan metabolism (Vecsei et al., 2013) . CSF QUIN levels are elevated during HIV-associated dementia in the absence of cART (Heyes et al., 1991) . The ratio of kynurenine to tryptophan (known at the K/T ratio) reflects increased activity of the kynurenine pathway and is associated with mortality when measured from the blood of HIV-infected individuals (Byakwaga et al., 2014) . Similarly, the CSF QUIN/T ratio was found to be the earliest predictor of neurological disease in untreated simian immunodeficiency virus (SIV)-infected macaques, and kynurenine pathway metabolites in the brain do not normalize in the SIV-infected brain despite cART (Drewes et al., 2015) .
There are also lingering questions as to whether HAND has any pathogenic similarities with Alzheimer's disease (AD), the most common dementia worldwide. The tau protein, which is critical for the stabilization of microtubules and neuronal integrity, is hyperphosphorylated in AD and other dementias (Brunden et al., 2009 ). Several studies have attempted to determine whether HIV is also associated with abnormal Tau levels and might represent a "Tauopathy". Studies in the pre-cART era focusing on total Tau (t-Tau) were small, and the results were conflicting (Andersson et al., 1999; Green et al., 2000) . More recent studies have focused on phosphorylated Tau (pTau), which is more specific for Tauopathy-associated dementias. Again, some studies found a relationship between increased CSF pTau and HAND (Brew et al., 2005) , while others did not (Clifford et al., 2009; Krut et al., 2016; Peterson et al., 2014) . 
